f-MKKFRW acetate
Based on 1 Customer Validation
f-MKKFRW acetate is a formylated MgrB signal sequence peptide and Fpr3 agonist. f-MKKFRW acetate can be produced by bacteria. f-MKKFRW acetate is selectively recognized by a subset of vomeronasal sensory neurons and activates Fpr3-expressing and B2m-expressing VSNs, but not NP2-expressing VSNs. f-MKKFRW acetate activates TRPM5-dependent signaling, triggering acetylcholine release. f-MKKFRW acetate drives innate avoidance behavior requiring Fpr3, Gαo, and Trpc2.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C44H66N12O8S·xC2H4O2
- Molecular Weight:923.14 (free base)
-
Speicherung:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[2]|
TRPM5 |
In Vitro
f-MKKFRW (8 min) acetate stimulates PTS in isolated mouse trachea through a chemosensory cell-dependent, TRPM5/PLCβ2/IP3R3-dependent, Atropine (HY-B1205)- and 4-DAMP-sensitive pathway[2].
f-MKKFRW (8 min) acetate increases the ciliary beating frequency in isolated mouse trachea from 8.7 Hz to 14.2 Hz[2].
f-MKKFRW (50 µM) acetate elicits transient Ca2+ elevation in a subset of TRPM5+ tracheal chemosensory cells (19/92; 21%)[2].
f-MKKFRW (10 µM; 15 min) acetate triggers TRPM5-dependent acetylcholine release in isolated mouse trachea, which can be detected by M3 reporter cells and HPLC[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6N and transgenic lines (B6; ΔFpr3-lacZ, cGαo, Trpc2; adult male; 8-14 weeks old for behavioral tests; adult male for in-vivo VSN activation)[1]
-
Dosage:100 μM in PBS; 100 μM final concentration in 50% FEU; 100 μM final concentration in FEU; 50 μM final concentration in FEU
-
Administration:oronasal application; single exposure; free investigation/nasal contact; 10 min
-
Result:In freely behaving mice, both oronasal application and free investigation at 100 μM induced Egr1 expression in approximately 50% of Fpr3-positive VSNs; this activation was not observed with control stimuli.
In behavioral tests, 100 μM elicited robust avoidance in B6 mice, ΔFpr3-lacZ+/+, cGαo+/−, and Trpc2+/− mice.
Mice still displayed avoidance at 50 μM.
Avoidance was absent in ΔFpr3-lacZ−/−, cGαo−/−, and Trpc2−/− mice.
Chemical Information
-
Appearance Solid
-
Molecular Weight 923.14 (free base)
-
Formel C44H66N12O8S·xC2H4O2
-
Sequence
{fMet}-Lys-Lys-Phe-Arg-Trp
-
Sequence Shortening
{fMet}-KKFRW
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : 100 mg/mL (Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
Reinheit & Dokumentation
-
Data Sheet (293 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)